For research access and to learn how you can work with Alembic Global Advisors please email Stephen Matthews, stephen.matthews@alembicglobal.com.
Key Points We’re updating our forecast for HEI post the firm’s 1QFY25 earnings release for the first time. We’re also reiterating our Overweight rating on the shares. We’ve raised our target price...
Key Points Share price decline overdone, valuation cheap, and debt levels manageable See company organically being able to pay down debt. If need be, asset sales could also accelerate debt paydown We are...
Key Points We’re updating our forecast for AVAV post last week’s 3QFY25 earnings release and reiterating our Overweight rating, though we’re lowering our target price. Our target price declines by USD42...
Key Points Outperformance of European chemical equities pointing to a positive inflection in fundamentals particularly if a Russia-Ukraine peace deal is brokered Do not see Europe giving up on their chemical industry...
Key Points We’re updating our forecast for KTOS post last week’s 4Q earnings report and reiterating our Overweight rating on the shares. We’re maintaining our USD37 target price (33x terminal multiple, 2x...